← Back to Search

Polyphenol-rich cranberry extract supplement standardized in proanthocyanidins for Abdominal Obesity (Neurocan Trial)

N/A
Recruiting
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Neurocan Trial Summary

This trial will test the effects of a cranberry extract on cardiometabolic and neurocognitive health in people with abdominal obesity. The study will last 8 weeks and involve 60 participants.

Eligible Conditions
  • Abdominal Obesity

Neurocan Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight Changes
Changes in brain density in key regions
Changes in cerebral vasculature
+6 more
Secondary outcome measures
Changes in attention span and short-term working memory
Changes in biomarkers of gut endotoxemia
Changes in biomarkers of gut permability
+3 more

Neurocan Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Polyphenol-rich cranberry extract supplement standardized in PACsExperimental Treatment1 Intervention
Supplementation with polyphenol-rich cranberry extract standardized in PACs (1 capsule / day)
Group II: Placebo supplementPlacebo Group1 Intervention
Supplementation with placebo (1 capsule / day)

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,212 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participation in this trial?

"This healthcare trial is recruiting 60 participants aged 30-70 with obesity and visceral fat. Eligible patients must have had a stable weight over the last 3 months, be between 30-65 years old, have a BMI of 30-40 kg/m2, access to technology such as computers and internet connections, and waist circumferences greater than 85 cm for females or 90 cm for males."

Answered by AI

What are the major goals of this research endeavor?

"Over the course of 8 weeks, we will be studying changes in functional brain connectivity as our primary outcome. As secondary objectives, we shall assess alterations to executive function (using Stroop), gut permeability (by analyzing blood plasma for zonulin) and body fat distribution (Abdominal axial T1-weighted slices)."

Answered by AI

Does this research trial include participants of a mature age?

"As stated in the requirements for this medical trial, applicants must be between 30 to 70 years of age."

Answered by AI

How many participants are included in this research project?

"Indeed, clinicaltrials.gov's records indicate that recruitment is ongoing for this trial, which was initially published on October 21st 2021 and last revised on September 26th 2022. The study seeks to enrol 60 individuals at a single medical facility."

Answered by AI

Are additional participants being accepted in this research project?

"According to the clinicaltrials.gov page, this research venture is currently in search of volunteers; it was first debuted on October 21st 2021 and recently updated on September 26th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
How old are they?
65+
What site did they apply to?
Quebec Heart and Lung Institute - Laval University
What portion of applicants met pre-screening criteria?
Met criteria
~17 spots leftby Apr 2025